Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks
Titel:
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks
Auteur:
Kiialainen, Anna Adamkewicz, Joanne I. Petry, Claire Oldenburg, Johannes Pipe, Steven W. Young, Guy Mahlangu, Johnny Lehle, Michaela Niggli, Markus Castaman, Giancarlo Jiménez-Yuste, Víctor Shima, Midori Négrier, Claude Schmitt, Christophe
Verschenen in:
Research and practice in thrombosis and haemostasis